Nigeria's Unique Travel Boom: Foreigners Flock for IVF Medical Tourism

Nigeria is increasingly emerging as a prominent destination for fertility patients from across Africa and the global diaspora, seeking in-vitro fertilisation (IVF) and other assisted reproductive treatments. This phenomenon, dubbed "reverse medical tourism" by fertility experts, is primarily driven by the comparatively lower cost of treatment in the country, despite the nation's reliance on imported drugs and materials for these procedures.

Fertility experts, speaking at a joint conference of the Association for Fertility and Reproductive Health (AFRH) and the African Federation of Fertility Societies (AFFS) in Abuja, highlighted Nigeria's developed capacity to provide advanced fertility treatment. However, they also advocated for critical reforms including stronger regulation of assisted reproductive technology, increased investment in research and local production of fertility drugs, and broader health insurance coverage to enhance access for Nigerians grappling with infertility.

Prof. Preye Fiebai, President of AFRH, acknowledged the significant progress within Nigeria's fertility sector, noting its under-recognition due to inadequate reporting of fertility treatment cycles. Fiebai asserted that Nigeria's substantial population and expanding treatment capabilities position it as a major hub for reproductive health services on the continent. He emphasized that despite high national fertility rates, infertility rates are also exceptionally high, a condition recognized by the World Health Organisation (WHO) as an ailment requiring appropriate medical attention, yet often receiving less attention than communicable diseases.

Fiebai underscored that Nigeria has evolved from offering basic fertility treatments to providing some of the most advanced reproductive technologies globally, affirming that the country is not lagging behind international standards. However, he identified the high cost of IVF as a primary barrier to access, largely attributing it to the nation's dependence on imported drugs and other necessary materials. He stressed the need for increased investment and collaboration to foster local alternatives and reduce import reliance, citing institutions like the Institute for Medical Science in Africa in Abuja as already pursuing innovative reproductive health research.

Poor data reporting within Nigeria's fertility industry further impedes its ability to attract adequate investment and international recognition. Fiebai explained that if Nigeria documented even a fraction of its IVF procedures, international pharmaceutical and medical companies would naturally pay greater attention due to higher recorded treatment volumes. He pointed out that despite the high cost locally, IVF treatment in Nigeria remains considerably cheaper than in many countries from which patients travel, explaining the ongoing "reverse medical tourism." Nevertheless, he lamented that many Nigerians who need fertility treatment cannot afford it due to prevailing socioeconomic conditions, urging government, health insurance providers, and other stakeholders to provide support.

Regarding regulation, Fiebai revealed ongoing engagement with the National Assembly on legislation for assisted reproductive technology, with fertility professionals having made submissions on a proposed Assisted Reproductive Technology Bill in 2023. He believes effective regulation is crucial for protecting patients, practitioners, and children born through these procedures, ensuring legislation considers the rights and long-term welfare of such children. On the controversial topic of abortion, Fiebai clarified that practitioners must adhere strictly to Nigerian law, where voluntary termination of pregnancy is generally illegal except under specific permitted circumstances.

Dr. Ibrahim Wada, immediate past president of AFRH, advocated for wider adoption of egg freezing as a means of preserving women's fertility, especially given that age significantly impacts reproductive capacity. He suggested that women not ready for children early in life could freeze their eggs for future use. Wada also highlighted the importance of fertility preservation for individuals undergoing medical treatments that could compromise their reproductive health, assuring that egg freezing is safe and available in Nigeria.

Dr. Sunday Onuh, Chairman of the Local Organising Committee for the upcoming conference, reiterated that the event aims to showcase Africa's growing capacity in fertility science and treatment. He noted that the continent is increasingly attracting international patients due to the quality and affordability of fertility services in some African nations, reinforcing the concept of "reverse medical tourism." The conference, themed "Fertility Frontiers, Global Innovations and Advances in Human Reproduction," is a deliberate effort to position Africa as a significant center for fertility science.

Paul La Roux, President of AFFS, expressed enthusiasm for the Abuja conference, scheduled from September 24 to 26, expecting participants from across Africa and beyond. Fiebai disclosed that over 1,000 fertility and reproductive health professionals, including doctors, nurses, embryologists, counsellors, and lawyers, are expected at the event, which marks Nigeria's first time hosting such a continental gathering. Mohamed Khrouf, President-elect of the AFFS, described the conference as the fulfillment of a long-held dream for African fertility professionals to establish a continental platform for collaboration, emphasizing the growing international interest in Africa's fertility sector.